Stephen Conway
Neurology · Hartford, CTNPI 1104866524
Payments from drug & device makers
Across 470 payments — averaging $17.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$845
- Sanofi$668
- Biogen$666
- Novartis$521
- AstraZeneca$369
- Amgen$326
- plus $5K from 46 others
What the payments were for
- Speaking & faculty fees$1992%
- Food & beverage$8,10398%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SOLIRIS$126
How this compares
$8,302 in reported general payments places this provider in the 60th percentile of 280 neurology providers in Connecticut.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PrivigenImmun Glob G(Igg)/Pro/Iga 0-50 | 12 | $143,660 |
| Nurtec OdtRimegepant Sulfate | 22 | $37,783 |
| Carbamazepine ErCarbamazepine | 18 | $2,604 |
| Carbamazepine | 18 | $1,455 |
| Levetiracetam | 41 | $1,306 |
| Gabapentin | 36 | $956 |
| Oxcarbazepine | 18 | $950 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 32 | $743 |
| Lamotrigine | 20 | $721 |
| Nortriptyline Hcl | 19 | $590 |
| Baclofen | 11 | $395 |
| Azathioprine | 16 | $301 |
| Topiramate | 18 | $149 |
| Ropinirole Hcl | 11 | $135 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| CSL BehringPrivigen | $147 | $143,66012 claims |
| PfizerNurtec Odt | $179 | $37,78322 claims |
| Upsher-smith Laboratories LLCTopiramate | $51 | $14918 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 280 neurology providers in Connecticut.
Other neurology in Hartford
- Peter WadeHartford$302K
- Veeresh Kumar Nanjangud ShivamurthyHartford$123K
- Alexis DemopoulosHartford$46K
- David RussellNew Haven$31.2M
- Peter McAllisterFairfield$15M
- Erin LongbrakeNorth Haven$5.5M
- David HaflerNew Haven$3.5M
- Stewart TepperStamford$1.3M
- Kathleen MullinStamford$1.1M
- Richard NowakNew Haven$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.